SLS:NASDAQ, SELLAS Life Sciences Group, Inc.

SLS stock overview

SELLAS Life Sciences Group, Inc. (SLS:NASDAQ) closed at $9.98 on October 16, 2026, down 11.99% on the day. The stock trades 37.2% below its 52-week high of $15.88 and 618.0% above its 52-week low of $1.39. Over the past year, it gained 366.4%. SELLAS Life Sciences Group, Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$9.98
Day change
-11.99%
Volume
15,765,579
Average volume
6,369,968
Market cap
2B+
52-week range
$1.39 – $15.88
50-day average
$12.46
200-day average
$8.19

Performance

5D 1M 3M 6M 1Y
-16.35% -13.44% -20.03% +100.00% +366.36%

Price action over the past year

In 252 trading sessions since October 16, 2025, SLS closed higher on 129 days (51%). Its best day was May 13, 2026 (+25.10%) and its worst was January 6, 2026 (-18.00%). The stock moved 10% or more in a single session 32 times. It opened at least 5% above the previous day's high 8 times.

Recent signals

SLS news

About SELLAS Life Sciences Group, Inc.

Galena Biopharma Inc is a biopharmaceutical company. It is focused on developing and commercializing targeted oncology therapeutics that addresses unmet medical needs.

Similar stocks

Find more stocks like SLS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.